Literature DB >> 20830827

The renaissance in HIV vaccine development--future directions.

C Koff Wayne1, Seth F Berkley.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20830827     DOI： 10.1056/NEJMp1007629

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  The cost-effectiveness of a modestly effective HIV vaccine in the United States.

Authors:  Elisa F Long; Douglas K Owens
Journal:  Vaccine       Date:  2011-04-19       Impact factor: 3.641

2.  Lack of uptake threatens promise of HIV vaccines.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2010-09       Impact factor: 53.440

Review 3.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

Review 4.  Cure for acquired immunodeficiency syndrome--a global battle.

Authors:  Jie Wang
Journal:  Chin J Integr Med       Date:  2013-12-18       Impact factor: 1.978

5.  Immune reconstitution--the footing of Chinese medicine treatment for acquired immunodeficiency syndrome.

Authors:  Jie Wang
Journal:  Chin J Integr Med       Date:  2011-05-25       Impact factor: 1.978

6.  The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results.

Authors:  Kyeen M Andersson; A David Paltiel; Douglas K Owens
Journal:  Vaccine       Date:  2011-07-05       Impact factor: 3.641

7.  "Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown.

Authors:  Peter A Newman; Carmen Logie; Llana James; Tamicka Charles; John Maxwell; Khaled Salam; Michael Woodford
Journal:  Am J Public Health       Date:  2011-07-21       Impact factor: 9.308

8.  HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development.

Authors:  Mangala Rao; Kristina K Peachman; Jiae Kim; Guofen Gao; Carl R Alving; Nelson L Michael; Venigalla B Rao
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

9.  HIV-1 envelope accessible surface and polarity: clade, blood, and brain.

Authors:  Gopichandran Sowmya; Gunasagaran Shamini; Sathyanarayanan Anita; Meena Sakharkar; Venkat Mathura; Hector Rodriguez; Andrew J Levine; Elyse Singer; Deborah Commins; Charurut Somboonwit; John T Sinnott; Harcharan S Sidhu; Ganapathy Rajaseger; Peter Natesan Pushparaj; Pandajarasamme Kangueane; Paul Shapshak
Journal:  Bioinformation       Date:  2011-03-22

10.  Broad antibody mediated cross-neutralization and preclinical immunogenicity of new codon-optimized HIV-1 clade CRF02_AG and G primary isolates.

Authors:  Simon M Agwale; Joseph C Forbi; Frank Notka; Terri Wrin; Jens Wild; Ralf Wagner; Hans Wolf
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.